Arkolith/Insider Trading/HRMY/Form 4

Kapadia Sandip

CHIEF FINANCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Jan 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$68K
Net Open-Market Flow
-$68K
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2025Sell(S)2K$38.05$68K0
Jan 24, 2025Tax withholding(F)2K$38.01$77K2K
Jan 24, 2025Option exercise(M)4K—$04K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 25, 2025Grant(A)19K—$019K
Jan 25, 2025Grant(A)66K—$066K
Jan 24, 2025Option exercise(M)4K—$011K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002158) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML